Solesence (SLSN) Stock Price
Solesence Price
Over the last 19 years Solesence grew revenue by 10.7% annually, reaching 62.06 M USD. Earnings per share have declined at 0.9% per year over the last 5 years. For Solesence, the net margin of 2.9% is down versus 7.9% a few years ago. The stock trades about 61% above its 52-week low.
Solesence stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Solesence over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Solesence stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Solesence's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Solesence Price |
|---|---|
| 8/6/2026 | 1.03 USD |
| 8/5/2026 | 1.07 USD |
| 8/4/2026 | 1.10 USD |
| 8/3/2026 | 0.99 USD |
| 7/31/2026 | 0.83 USD |
| 7/30/2026 | 0.82 USD |
| 7/29/2026 | 0.92 USD |
| 7/27/2026 | 0.98 USD |
| 7/23/2026 | 1.00 USD |
| 7/22/2026 | 0.85 USD |
| 7/21/2026 | 0.77 USD |
| 7/20/2026 | 0.73 USD |
| 7/17/2026 | 0.78 USD |
| 7/16/2026 | 0.78 USD |
| 7/15/2026 | 0.83 USD |
| 7/14/2026 | 0.64 USD |
| 7/13/2026 | 0.73 USD |
| 7/10/2026 | 0.68 USD |
| 7/9/2026 | 0.70 USD |
| 7/8/2026 | 0.74 USD |
| 7/7/2026 | 0.72 USD |
| 7/6/2026 | 0.69 USD |
| 7/2/2026 | 0.68 USD |
| 7/1/2026 | 0.73 USD |
| 6/30/2026 | 0.74 USD |
| 6/29/2026 | 0.80 USD |
| 6/26/2026 | 0.82 USD |
| 6/25/2026 | 1.04 USD |
| 6/24/2026 | 1.11 USD |
| 6/23/2026 | 1.30 USD |
| 6/22/2026 | 1.30 USD |
| 6/18/2026 | 1.34 USD |
| 6/17/2026 | 1.28 USD |
| 6/16/2026 | 1.36 USD |
| 6/15/2026 | 1.26 USD |
| 6/12/2026 | 1.33 USD |
| 6/11/2026 | 1.25 USD |
| 6/10/2026 | 1.12 USD |
| 6/9/2026 | 1.22 USD |
| 6/8/2026 | 1.20 USD |
| 6/5/2026 | 1.31 USD |
| 6/4/2026 | 1.35 USD |
| 6/3/2026 | 1.26 USD |
| 6/2/2026 | 1.39 USD |
| 6/1/2026 | 1.30 USD |
| 5/29/2026 | 1.23 USD |
| 5/28/2026 | 1.32 USD |
| 5/27/2026 | 1.23 USD |
| 5/26/2026 | 1.28 USD |
| 5/22/2026 | 1.25 USD |
| 5/21/2026 | 1.26 USD |
| 5/20/2026 | 1.36 USD |
| 5/19/2026 | 1.19 USD |
| 5/18/2026 | 1.25 USD |
| 5/15/2026 | 1.21 USD |
| 5/14/2026 | 1.31 USD |
| 5/13/2026 | 1.32 USD |
| 5/12/2026 | 1.24 USD |
| 5/11/2026 | 1.50 USD |
| 5/8/2026 | 1.35 USD |
| 5/7/2026 | 1.30 USD |
| 5/6/2026 | 1.26 USD |
| 5/5/2026 | 1.28 USD |
| 5/4/2026 | 1.29 USD |
| 5/1/2026 | 1.34 USD |
| 4/30/2026 | 1.34 USD |
| 4/29/2026 | 1.30 USD |
| 4/28/2026 | 1.37 USD |
| 4/27/2026 | 1.39 USD |
| 4/24/2026 | 1.21 USD |
| 4/23/2026 | 1.12 USD |
| 4/22/2026 | 1.15 USD |
| 4/21/2026 | 1.10 USD |
| 4/20/2026 | 1.22 USD |
| 4/17/2026 | 1.25 USD |
| 4/16/2026 | 1.21 USD |
| 4/15/2026 | 1.15 USD |
| 4/14/2026 | 1.10 USD |
| 4/13/2026 | 1.19 USD |
| 4/10/2026 | 1.11 USD |
| 4/9/2026 | 1.15 USD |
| 4/8/2026 | 1.31 USD |
| 4/7/2026 | 1.21 USD |
| 4/6/2026 | 1.41 USD |
| 4/2/2026 | 1.40 USD |
| 4/1/2026 | 1.08 USD |
| 3/31/2026 | 0.95 USD |
| 3/30/2026 | 0.90 USD |
| 3/27/2026 | 0.91 USD |
| 3/26/2026 | 0.94 USD |
| 3/25/2026 | 0.88 USD |
| 3/24/2026 | 0.90 USD |
| 3/23/2026 | 0.86 USD |
| 3/20/2026 | 0.88 USD |
| 3/19/2026 | 0.86 USD |
| 3/18/2026 | 0.81 USD |
| 3/17/2026 | 0.96 USD |
| 3/16/2026 | 0.95 USD |
| 3/13/2026 | 0.95 USD |
| 3/12/2026 | 1.01 USD |
| 3/11/2026 | 1.05 USD |
| 3/10/2026 | 1.08 USD |
| 3/9/2026 | 1.01 USD |
| 3/6/2026 | 1.01 USD |
| 3/5/2026 | 1.08 USD |
| 3/4/2026 | 1.18 USD |
| 3/3/2026 | 1.18 USD |
| 3/2/2026 | 1.29 USD |
| 2/27/2026 | 1.28 USD |
| 2/26/2026 | 1.31 USD |
| 2/25/2026 | 1.33 USD |
| 2/24/2026 | 1.23 USD |
| 2/23/2026 | 1.16 USD |
| 2/20/2026 | 1.27 USD |
| 2/19/2026 | 1.25 USD |
| 2/18/2026 | 1.32 USD |
| 2/17/2026 | 1.37 USD |
| 2/13/2026 | 1.33 USD |
| 2/12/2026 | 1.26 USD |
| 2/11/2026 | 1.30 USD |
| 2/10/2026 | 1.44 USD |
| 2/9/2026 | 1.39 USD |
| 2/6/2026 | 1.37 USD |
| 2/5/2026 | 1.33 USD |
| 2/4/2026 | 1.40 USD |
| 2/3/2026 | 1.42 USD |
| 2/2/2026 | 1.48 USD |
| 1/30/2026 | 1.35 USD |
| 1/29/2026 | 1.32 USD |
| 1/28/2026 | 1.45 USD |
| 1/27/2026 | 1.56 USD |
| 1/26/2026 | 1.52 USD |
| 1/23/2026 | 1.48 USD |
| 1/22/2026 | 1.56 USD |
| 1/21/2026 | 1.63 USD |
| 1/20/2026 | 1.52 USD |
| 1/16/2026 | 1.53 USD |
| 1/15/2026 | 1.56 USD |
| 1/14/2026 | 1.52 USD |
| 1/13/2026 | 1.52 USD |
| 1/12/2026 | 1.54 USD |
| 1/9/2026 | 1.51 USD |
| 1/8/2026 | 1.53 USD |
| 1/7/2026 | 1.50 USD |
| 1/6/2026 | 1.53 USD |
| 1/5/2026 | 1.58 USD |
| 1/2/2026 | 1.50 USD |
| 12/31/2025 | 1.60 USD |
| 12/30/2025 | 1.66 USD |
| 12/29/2025 | 1.72 USD |
| 12/26/2025 | 1.81 USD |
| 12/24/2025 | 1.89 USD |
| 12/23/2025 | 1.80 USD |
| 12/22/2025 | 1.93 USD |
| 12/19/2025 | 2.04 USD |
| 12/18/2025 | 2.03 USD |
| 12/17/2025 | 2.04 USD |
| 12/16/2025 | 2.02 USD |
| 12/15/2025 | 2.02 USD |
| 12/12/2025 | 2.06 USD |
| 12/11/2025 | 2.19 USD |
| 12/10/2025 | 2.21 USD |
| 12/9/2025 | 2.07 USD |
| 12/8/2025 | 1.97 USD |
| 12/5/2025 | 2.05 USD |
| 12/4/2025 | 2.17 USD |
| 12/3/2025 | 2.12 USD |
| 12/2/2025 | 2.04 USD |
| 12/1/2025 | 2.12 USD |
| 11/28/2025 | 2.29 USD |
| 11/26/2025 | 2.17 USD |
| 11/25/2025 | 2.25 USD |
| 11/24/2025 | 2.14 USD |
| 11/21/2025 | 2.21 USD |
| 11/20/2025 | 2.06 USD |
| 11/19/2025 | 1.96 USD |
| 11/18/2025 | 1.87 USD |
| 11/17/2025 | 1.88 USD |
| 11/14/2025 | 1.83 USD |
| 11/13/2025 | 1.64 USD |
| 11/12/2025 | 1.94 USD |
| 11/11/2025 | 2.13 USD |
| 11/10/2025 | 2.81 USD |
| 11/7/2025 | 2.94 USD |
| 11/6/2025 | 3.08 USD |
| 11/5/2025 | 3.28 USD |
| 11/4/2025 | 3.17 USD |
| 11/3/2025 | 3.23 USD |
| 10/31/2025 | 3.27 USD |
| 10/30/2025 | 3.28 USD |
| 10/29/2025 | 3.51 USD |
| 10/28/2025 | 3.69 USD |
| 10/27/2025 | 3.58 USD |
| 10/24/2025 | 3.70 USD |
| 10/23/2025 | 3.70 USD |
| 10/22/2025 | 3.75 USD |
| 10/21/2025 | 3.74 USD |
| 10/20/2025 | 3.88 USD |
| 10/17/2025 | 3.82 USD |
| 10/16/2025 | 3.91 USD |
| 10/15/2025 | 3.98 USD |
| 10/14/2025 | 3.75 USD |
| 10/13/2025 | 3.59 USD |
| 10/10/2025 | 3.56 USD |
| 10/9/2025 | 3.64 USD |
| 10/8/2025 | 3.76 USD |
| 10/7/2025 | 3.54 USD |
| 10/6/2025 | 3.67 USD |
| 10/3/2025 | 4.03 USD |
| 10/2/2025 | 4.36 USD |
| 10/1/2025 | 3.24 USD |
| 9/30/2025 | 3.22 USD |
| 9/29/2025 | 3.20 USD |
| 9/26/2025 | 3.31 USD |
| 9/25/2025 | 3.23 USD |
| 9/24/2025 | 3.43 USD |
| 9/23/2025 | 3.34 USD |
| 9/22/2025 | 3.37 USD |
| 9/19/2025 | 3.46 USD |
| 9/18/2025 | 3.44 USD |
| 9/17/2025 | 3.25 USD |
| 9/16/2025 | 3.28 USD |
| 9/15/2025 | 3.43 USD |
| 9/12/2025 | 3.37 USD |
| 9/11/2025 | 3.39 USD |
| 9/10/2025 | 3.33 USD |
| 9/9/2025 | 3.23 USD |
| 9/8/2025 | 3.31 USD |
| 9/5/2025 | 3.26 USD |
| 9/4/2025 | 3.53 USD |
| 9/3/2025 | 3.50 USD |
| 9/2/2025 | 3.63 USD |
| 8/29/2025 | 3.66 USD |
| 8/28/2025 | 3.53 USD |
| 8/27/2025 | 3.59 USD |
| 8/26/2025 | 3.52 USD |
| 8/25/2025 | 3.50 USD |
| 8/22/2025 | 3.75 USD |
| 8/21/2025 | 3.48 USD |
| 8/20/2025 | 3.50 USD |
| 8/19/2025 | 3.37 USD |
| 8/18/2025 | 3.58 USD |
| 8/15/2025 | 3.90 USD |
| 8/14/2025 | 3.63 USD |
| 8/13/2025 | 3.66 USD |
| 8/12/2025 | 3.79 USD |
| 8/11/2025 | 3.53 USD |
Solesence Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Solesence Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.00 | 9.00 | 10.00 | 9.00 | 9.00 | 10.00 | 10.00 | 12.00 | 14.00 | 12.00 | 17.00 | 29.00 | 37.00 | 37.00 | 52.00 | 62.00 |
| 50.00 | – | 11.11 | -10.00 | – | 11.11 | – | 20.00 | 16.67 | -14.29 | 41.67 | 70.59 | 27.59 | – | 40.54 | 19.23 |
| 22.22 | 22.22 | 20.00 | 22.22 | 22.22 | 30.00 | 30.00 | 25.00 | 21.43 | 16.67 | 29.41 | 27.59 | 21.62 | 18.92 | 30.77 | 25.81 |
| 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 5.00 | 8.00 | 8.00 | 7.00 | 16.00 | 16.00 |
| -3.00 | -3.00 | -2.00 | -2.00 | -1.00 | -1.00 | -1.00 | – | -2.00 | -2.00 | 1.00 | 2.00 | -2.00 | -3.00 | 5.00 | 2.00 |
| -33.33 | -33.33 | -20.00 | -22.22 | -11.11 | -10.00 | -10.00 | – | -14.29 | -16.67 | 5.88 | 6.90 | -5.41 | -8.11 | 9.62 | 3.23 |
| -4.00 | -3.00 | -2.00 | -2.00 | -1.00 | -1.00 | -1.00 | – | -2.00 | -3.00 | – | 2.00 | -2.00 | -4.00 | 4.00 | 1.00 |
| – | -25.00 | -33.33 | – | -50.00 | – | – | – | – | 50.00 | – | – | -200.00 | 100.00 | -200.00 | -75.00 |
| 21.20 | 21.21 | 24.48 | 28.47 | 28.48 | 28.57 | 30.91 | 31.34 | 33.87 | 36.60 | 38.55 | 47.00 | 49.00 | 49.63 | 70.01 | 72.81 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Solesence generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Solesence retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Solesence's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Solesence has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Solesence's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Solesence stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Solesence Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Solesence business model & stock analysis
Solesence SWOT Analysis
Strengths
Nanophase Technologies Corp exhibits several strengths that contribute to its competitive advantage and market position. Firstly, the company possesses advanced nanotechnology expertise, allowing it to develop innovative products with enhanced properties and superior performance. This technological leadership serves as a significant advantage over competitors in the industry.
Secondly, Nanophase Technologies Corp has a diverse product portfolio, catering to various industries such as automotive, electronics, and energy sectors. This broad product range not only helps the company to capture different market segments but also mitigates the risk of over-reliance on a single industry.
Furthermore, the company has established strong strategic partnerships with key players in the industry. These collaborations enable Nanophase Technologies Corp to leverage the networks and resources of its partners, expanding its market reach and enhancing its distribution capabilities.
Weaknesses
Despite its strengths, Nanophase Technologies Corp faces certain weaknesses that pose challenges to its operations. One weakness is the potential high cost associated with the development and commercialization of nanotechnology products. This may limit the company's ability to price its offerings competitively, especially when compared to conventional alternatives available in the market.
Additionally, the company's product development cycle may be relatively longer due to the complexity of nanotechnology. This can put Nanophase Technologies Corp at a disadvantage, as competitors with shorter development timelines may capitalize on market opportunities faster.
Moreover, maintaining a talented pool of nanotechnology experts can be challenging. The niche nature of nanotechnology and its rapidly evolving landscape necessitate continuous training and recruitment efforts to retain a skilled workforce.
Opportunities
Nanophase Technologies Corp has several opportunities to capitalize on in the market. With increasing demand for advanced and functional materials, the company can leverage its nanotechnology expertise to develop new products that offer improved performance, durability, and efficiency. This can lead to market expansion and increased sales.
The growing focus on sustainable and environmentally friendly technologies presents another opportunity for Nanophase Technologies Corp. By developing nanomaterials that are eco-friendly and energy-efficient, the company can align itself with the trend toward sustainable practices, potentially attracting environmentally conscious customers and gaining a competitive edge.
Furthermore, expanding into emerging markets, such as Asia-Pacific and Latin America, can provide Nanophase Technologies Corp with significant growth opportunities. These regions show increasing demand for advanced materials, driven by rapid industrialization and infrastructure development.
Threats
Several external factors pose threats to Nanophase Technologies Corp. Intense competition within the nanotechnology sector can result in price wars, eroding profit margins. The presence of well-established competitors with their own technological advancements and distribution networks necessitates continuous innovation and differentiation to stay competitive.
Additionally, changes in government regulations and policies related to nanotechnology, including safety and environmental regulations, can pose compliance challenges and increase operational costs for Nanophase Technologies Corp. Adapting to these regulatory changes may require substantial investments in research and development and manufacturing processes.
Economic fluctuations and volatile raw material prices are also significant threats. Nanophase Technologies Corp must carefully monitor market conditions to mitigate the impact of economic downturns and fluctuations in the availability and cost of key inputs.
Solesence Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Solesence Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Solesence historical P/E ratio, EBIT multiple, and P/S ratio
Solesence annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Solesence shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Solesence Earnings Calls
Solesence shareholder structure
| % | Name |
|---|---|
2.95818% | |
1.48624% | |
1.40137% | |
0.63905% | |
0.57979% | |
0.16514% |
Solesence Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
71.00% | SEC ↗ | |
70.90% | SEC ↗ | |
70.90% | SEC ↗ | |
43.30% | SEC ↗ | |
14.80% | SEC ↗ | |
7.01% | SEC ↗ | |
6.10% | SEC ↗ | |
5.70% | SEC ↗ | |
5.17% | SEC ↗ | |
3.70% | SEC ↗ |
Solesence Executives and Management Board
6 members · avg. age 59 · 67 % women
Mr. Kevin Cureton (64)
President, Chief Executive Officer, Director · since 2012
838,951.00 USD
Management
Ms. Laura Riffner
Chief Financial Officer
Ms. Yoana Dvorzsak
Vice President - Innovation and Product Integrity
Board of Directors
Ms. Rebecca Whitmore (70)
Chairman of the Board
Ms. Laura Beres (40)
Independent Director
Mr. Mark Miller (62)
Independent Director
Frequently asked questions about Solesence
Nanophase Technologies Corp is a company that focuses on the production and sale of nanomaterials. Their business model revolves around providing advanced materials solutions to various industries. Nanophase Technologies Corp develops and commercializes nanomaterials with unique performance attributes, including conductivity, scratch resistance, and UV protection, among others. By partnering with customers to understand their specific needs, Nanophase Technologies Corp is able to tailor their nanomaterials to enhance the performance and value of their products. With a strong emphasis on innovation and customer-centric approach, Nanophase Technologies Corp aims to be a leading provider of nanomaterials in the market.
Nanophase Technologies Corp is primarily active in the industries of advanced materials and nanotechnology. With a focus on innovation and nanomaterials, Nanophase Technologies Corp specializes in developing and commercializing advanced materials for various applications. The company's expertise lies in creating nanomaterials with unique properties that enhance performance in industries such as electronics, energy, healthcare, and personal care. Nanophase Technologies Corp leverages its nanotechnology advancements to provide solutions that improve functionality, durability, and efficiency across a range of industries.
Nanophase Technologies Corp faces competition in the market from various companies, including prominent players such as Nanometrics Inc., Cabot Corporation, and Cima NanoTech. These competitors operate in similar sectors and offer similar products, but with their own unique selling points and market positioning. Nanophase Technologies Corp distinguishes itself through its advanced nanoengineered materials and innovative solutions. By continually investing in research and development, Nanophase aims to maintain its competitive edge and capture a significant share of the market.
Nanophase Technologies Corp is a leading provider of advanced materials and solutions. Founded in 1989, the company has a rich history of innovation and expertise in nanomaterials. Nanophase Technologies Corp specializes in the design, development, and manufacturing of nano-engineered materials for various applications, including electronics, energy, and healthcare. With a strong focus on research and development, the company has been at the forefront of nanotechnology, continuously exploring and commercializing new materials and processes. Nanophase Technologies Corp has established itself as a trusted partner for industries seeking cutting-edge solutions in nanotechnology, driving advancements and shaping the future of advanced materials.
Some of the significant milestones achieved by Nanophase Technologies Corp include the development of cutting-edge nanomaterials and nanotechnology applications. The company has successfully expanded its product portfolio and established partnerships with leading industries. Nanophase Technologies Corp has also received multiple awards and recognition for its advancements in nanotechnology. It has consistently demonstrated its commitment to innovation and has made significant contributions to various sectors, such as energy, electronics, and healthcare.
Nanophase Technologies Corp is primarily present in the United States.
Nanophase Technologies Corp represents a strong commitment to innovation and excellence in the nanomaterials industry. With a focus on advancing technology and delivering tailored solutions, the company enables a wide range of applications across various sectors. Their corporate philosophy revolves around fostering collaboration, ensuring customer satisfaction, and maintaining a sustainable approach to business. Nanophase Technologies Corp prioritizes continuous research and development, leveraging their expertise in nanotechnology to enhance products and create value for their clients. By consistently striving for cutting-edge advancements, Nanophase Technologies Corp establishes itself as a leading player in the nanomaterials market.
Converted at the current exchange rate, the Solesence share trades at 0.89 EUR (1.03 USD).
Nanophase Technologies Corp is a company specialized in the production of nanoparticles and nanotechnological materials. It was founded in 1989 and its headquarters are located in Romeoville, Illinois. The company's business model is divided into three main divisions: Electronic Materials, Personal Care, and Performance Additives. Each division has its own products and customers. In the Electronic Materials division, Nanophase produces various nanoparticle-based materials used in the electronics industry, such as silver, silicon oxide, zinc oxide, and tin oxide nanoparticles. These materials enhance the conductivity of electronic components, leading to greater efficiency and reliability. The Personal Care division manufactures products for the cosmetics industry, including sunscreen containing nanoparticles that protect the skin from harmful UV rays. Nanophase also develops hair care and other cosmetic products. The Performance Additives division offers a wide range of products for various industries. Examples include coatings, where nanoparticles enhance wear resistance and durability, and polymer-based products used in medical and electronics industries. Nanophase has also developed energy-related products, such as nanoparticle-based batteries with higher energy density and faster charging capabilities than traditional batteries. The company has a strong research and development department that constantly develops new products and applications for nanoparticles and nanotechnological materials. Nanophase has a strong presence in the global market, supplying customers in North America, Europe, and Asia. Its business model focuses on providing specialized products tailored to meet customer needs, allowing the company to establish a foothold in various industries and achieve high customer satisfaction. Overall, Nanophase Technologies Corp is a successful company specializing in the application of nanoparticles and nanotechnological materials. Its wide range of products and applications is utilized by industries worldwide, contributing to technological advancement and innovation.
The revenue cannot currently be calculated for Solesence.
The profit cannot currently be calculated for Solesence.
The P/E ratio cannot be calculated for Solesence at the moment.
The P/S cannot be calculated for Solesence currently.
The Eulerpool Quality Score for Solesence is 5/10.
The ISIN of Solesence is US6300791018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Solesence is 910885. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Solesence is SLSN. The ticker symbol is used to trade Solesence shares on the stock exchange.
Solesence paid dividends every year for the past 0 years.
Solesence is assigned to the 'Commodities' sector.
The dividends of Solesence are distributed in USD.
Solesence stock
Solesence Peer Group
Solesence Ticker
Solesence FIGI
All fundamentals and in-depth analysis of Solesence
Our stock analysis for Solesence stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Solesence. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.